Pages that link to "Item:Q6050955"
From MaRDI portal
The following pages link to Evaluation of longitudinal surrogate markers (Q6050955):
Displaying 13 items.
- Assessing the value of a censored surrogate outcome (Q118842) (← links)
- Using earlier measures in a longitudinal sequence as a potential surrogate for a later one (Q962388) (← links)
- A shrinkage approach for estimating a treatment effect using intermediate biomarker data in clinical trials (Q2893404) (← links)
- Using a surrogate marker for early testing of a treatment effect (Q5121040) (← links)
- Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker (Q5222223) (← links)
- Prospective Accuracy for Longitudinal Markers (Q5459574) (← links)
- Identification and efficacy of longitudinal markers for survival (Q5701126) (← links)
- Evaluating multiple surrogate markers with censored data (Q6055488) (← links)
- Robust methods to correct for measurement error when evaluating a surrogate marker (Q6055522) (← links)
- Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy (Q6055756) (← links)
- Robust Approach to Combining Multiple Markers to Improve Surrogacy (Q6079767) (← links)
- Testing for Heterogeneity in the Utility of a Surrogate Marker (Q6079768) (← links)
- Flexible evaluation of surrogate markers with Bayesian model averaging (Q6630321) (← links)